Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.145 CAD | +7.41% | -3.33% | +81.25% |
26/03 | Marvel Biosciences Corp. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 | CI |
25/03 | Marvel Biosciences Announces Positive Interim Results For MB-204 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+81.25% | 39.31L | |
+22.93% | 4.5TCr | |
+1.08% | 4.26TCr | |
+45.83% | 4.18TCr | |
-4.27% | 2.9TCr | |
+10.80% | 2.61TCr | |
-20.95% | 1.9TCr | |
+6.79% | 1.28TCr | |
+28.08% | 1.21TCr | |
-4.37% | 1.18TCr |
- Stock Market
- Equities
- MRVL Stock
- News Marvel Biosciences Corp.
- Marvel Biosciences Completes Manufacturing Milestone Ahead of Phase 1 Trials Targeting Alzheimer's Disease, Depression